NCI Opportunities of Interest to the Innovator Community:

  1. Funding for Provocative Questions Now Available; Letters of Intent due May 20
  2. Request for Information (RFI) Regarding Opportunities for Cancer-relevant Innovative Technologies with Transformative Potential

 

Funding for Provocative Questions Now Available

The National Cancer Institute (NCI) is looking for bold new approaches to answer 24 perplexing scientific questions identified by the community. Apply for funding to find the answer to one of those questions!

Submit a Letter of Intent by May 20, 2013.
Applications are due June 20, 2013.

The Provocative Questions Initiative has assembled a list of important questions to stimulate the NCI’s research communities to use laboratory, clinical, and population sciences in especially effective and imaginative ways to answer the questions. Researchers from all sectors are invited to apply for grant funding in four thematic areas:

  • Cancer Prevention and Risk
  • Mechanisms of Tumor Development or Recurrence
  • Tumor Detection, Diagnosis, and Prognosis
  • Cancer Therapy and Outcomes

 
Please note that this is not an SBIR/STTR award, but small businesses are eligible to apply for R01 and R21 grants.

View the list of Provocative Questions and current Funding Opportunity Announcements at: provocativequestions.nci.nih.gov. If there are any questions about this initiative, please email NCIProvocativeQuestions@mail.nih.gov.

 

Request for Information (RFI) Regarding Opportunities for Cancer-relevant Innovative Technologies with Transformative Potential

The NCI invites feedback from cancer researchers, clinicians, and other interested members of the community through a Request for Information (RFI).

The purpose of the RFI is to seek input on the most important needs and promising opportunities to develop technologies with strong potential for accelerating cancer research or clinical care. NCI is interested in understanding the communities’ perspective on areas where state-of-the-art capabilities are insufficient for clinical care or to explore biological or epidemiological facets of cancer.

Responses to the RFI will be used for consideration of research priorities and may help to develop future funding opportunities for the Innovative Molecular Analysis Technologies (IMAT) Program.

Please click here for a list of currently open funding opportunities available as part of the IMAT Program. Please note that this is not an SBIR/STTR award, but small businesses are eligible to apply for R21 and R33 grants.

How to Submit a Response
Responses will be accepted through June 30, 2013 and should be marked with this RFI identifier “NOT-CA-13-009.” Responses are preferred in electronic format and should be e-mailed to nciimat@mail.nih.gov. View the RFI for additional instructions on how to respond: http://grants.nih.gov/grants/guide/notice-files/NOT-CA-13-009.html.

Join Dr. Tony Dickherber for a Town Hall
Ask questions and receive additional insight during a teleconference on May 29 at 3:00 p.m. ET. Dial 1-800-593-0693 and use the passcode “NCI.”

 

The SBIR & STTR Programs are NCI’s engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer. The SBIR & STTR Programs are government set-aside programs for domestic small businesses to engage in research and development that has the potential for commercialization and public benefit.

Sign up to receive updates about
SBIR & STTR funding opportunities at
sbir.cancer.gov

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: